1,25(OH)2D3 suppression of Sp1/NF-Y transactivation of the human PTH promoter requires an intact AF-2 domain

被引：0
|
作者：
Koszewski, NJ
Alimov, AP
Park-Sarge, O
Sarge, KD
Malluche, HH
机构：
[1] Univ Kentucky, Div Nephrol Bone Mineral Metab, Med Ctr, Lexington, KY 40506 USA
[2] Univ Kentucky, Dept Physiol, Med Ctr, Lexington, KY 40506 USA
[3] Univ Kentucky, Dept Mol & Cellular Biochem, Med Ctr, Lexington, KY 40506 USA
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S463 / S463
页数：1
相关论文
共 50 条
  • [31] PRODUCTION OF 1,25(OH)2D3 AND 24,25(OH)2D3 BY HUMAN-BONE CELLS-INVITRO
    HOWARD, GA
    TURNER, RT
    SHERRARD, DJ
    BAYLINK, DJ
    CLINICAL RESEARCH, 1981, 29 (02): : A409 - A409
  • [32] IS 1,25(OH)2D3 EFFECTIVE IN CHRONIC OSTEOMYELOFIBROSIS
    EUGSTER, C
    DELRE, GPB
    BUCHER, U
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 116 (50) : 1767 - 1770
  • [33] 1,25(OH)2D3 AND 25-OHD3 IN THE TREATMENT OF RENAL OSTEODYSTROPHY - COMPARISON OF COMBINED VERSUS 1,25(OH)2D3 ADMINISTRATION ALONE
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    BIANCHINI, G
    MATTEUCCI, MC
    MAZZAFERRO, S
    PICCA, S
    TAGGI, F
    CINOTTI, GA
    CASCIANI, CU
    MINERAL AND ELECTROLYTE METABOLISM, 1983, 9 (01) : 19 - 27
  • [34] EFFECTS OF CHRONIC METABOLIC ALKALOSIS ON CA-2+, PTH, AND 1,25(OH)2D3 IN THE RAT
    BUSHINSKY, DA
    KITTAKA, MK
    WEISINGER, JR
    LANGMAN, CB
    FAVUS, MJ
    AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (04): : E578 - E582
  • [35] IMPAIRED METABOLISM OF 1,25(OH)2D3 IN CHICKS TREATED WITH EHDP AND SUBSISTED ON 1,25(OH)2D3 AS THEIR SOLE SOURCE OF VITAMIN-D
    LIDOR, C
    WASSERMAN, RH
    EDLESTEIN, S
    BONE, 1986, 7 (05) : 392 - 392
  • [36] 1,25DIHYDROXYVITAMIN-D3 (1,25(OH)2D3) RECEPTORS IN HUMAN-LEUKEMIA CELLS
    SIMPSON, RU
    THOMAS, GA
    DIARD, L
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 486 - 486
  • [37] Higher 25(OH)D2 Is Associated With Lower 25(OH)D3 and 1,25(OH)2D3
    Swanson, Christine M.
    Nielson, Carrie M.
    Shrestha, Smriti
    Lee, Christine G.
    Barrett-Connor, Elizabeth
    Jans, Ivo
    Cauley, Jane A.
    Boonen, Steven
    Bouillon, Roger
    Vanderschueren, Dirk
    Orwoll, Eric S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08): : 2736 - 2744
  • [38] NF-Y, SP1 and SP3 transcription factors are involved in the regulation of human cathepsin L promoter
    Jean, D
    Guillaume, N
    Frade, R
    FASEB JOURNAL, 2002, 16 (04): : A667 - A667
  • [39] DIFFERENT EFFECTS OF 1,24(OH)2D3 AND 1,25(OH)2D3 - INVIVO AND INVITRO STUDIES
    ADAMI, S
    ROSSINI, M
    SUPPI, R
    BERTOLDO, F
    CAPPELLI, R
    ROSINI, S
    LOCASCIO, V
    CALCIFIED TISSUE INTERNATIONAL, 1986, 39 : A90 - A90
  • [40] THE SYNTHESIS OF 1,25(OH)2D3 AND 24,25(OH)2D3 BY CHICK CHORIOALLANTOIC (CA) CELLS
    PUZAS, JE
    TURNER, RT
    FORTE, M
    BAYLINK, DJ
    CALCIFIED TISSUE INTERNATIONAL, 1980, 31 (01) : 83 - 83
12345